Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 8/20 | 0.44 |
| ▸ | CA1 | P00915 | 4/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.37 |
| ▸ | FDPS | P14324 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.33 |
| ▸ | NAAA | Q02083 | 1/20 | 0.33 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.33 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.33 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27953181 | 0.84 | CA2 (0.43) | CA2CA1MAPK1ZDHHC7TSHR | |
| SCHEMBL28846728 | 0.81 | CA2 (0.38) | CA2CA1MAPK1ZDHHC7FDPS | |
| SCHEMBL5165914 | 0.80 | CA2 (0.45) | CA2CA1MAPK1ZDHHC7FDPS | |
| SCHEMBL26940441 | 0.80 | CA2 (0.50) | CA2CA1MAPK1ZDHHC7TDP1 | |
| SCHEMBL1784628 | 0.80 | CA2 (0.45) | CA2CA1MAPK1ZDHHC7FDPS | |
| SCHEMBL192696 | 0.80 | CA2 (0.50) | CA2CA1MAPK1ZDHHC7TDP1 | |
| SCHEMBL11428429 | 0.79 | FDPS (0.47) | CA2CA1FDPS | |
| SCHEMBL5200841 | 0.78 | CA2 (0.59) | CA2CA1MAPK1ZDHHC7TSHR | |
| SCHEMBL25582929 | 0.78 | CA2 (0.52) | CA2CA1MAPK1ZDHHC7FDPS | |
| SCHEMBL16908584 | 0.78 | CA2 (0.52) | CA2CA1MAPK1ZDHHC7FDPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107787337-A | Aldimines and ketimines as initiators in curing agent systems and corresponding resin compositions, in particular for fixing technology | 费希尔厂有限责任两合公司 | 2018-03-09 | — | — | CN | claimed |
| CN-102648230-B | The extremely low low viscosity epoxy resin compositions of blushing | SIKA技术股份公司 | 2017-03-01 | — | — | CN | claimed |
| CN-110402277-A | Water swellable moisture cured mono-component polyurethane sealant | SIKA TECH AG | 2019-11-01 | — | — | CN | disclosed |
| CN-106986867-B | Heterocycle amine as PI3K inhibitor | 因塞特控股公司 | 2019-06-28 | — | — | CN | disclosed |
| CN-208917109-U | Minodronate intermediate synthesis system | 南京拉艾夫医药科技有限公司 | 2019-05-31 | — | — | CN | disclosed |
| CN-109678859-A | Dihydropyrimidines and its application in drug | 广东东阳光药业有限公司 | 2019-04-26 | — | — | CN | disclosed |
| CN-109600993-A | Anti-EGFR antibody drug conjugates | 艾伯维公司 | 2019-04-09 | — | — | CN | disclosed |
| CN-109563167-A | ANTI-B7-H3 ANTIBODIES AND ANTIBODY DRUG CONJUGATES | 艾伯维公司 | 2019-04-02 | — | — | CN | disclosed |
| CN-109563232-A | With the mechanical performance not being affected by temperature substantially and high-intensitive two component polyurethane adhesive | SIKA技术股份公司 | 2019-04-02 | — | — | CN | disclosed |
| CN-109562169-A | anti-CD 98 antibodies and antibody drug conjugates | 艾伯维公司 | 2019-04-02 | — | — | CN | disclosed |
| CN-106132928-B | Anil, the medical composition and its use containing the derivative | 橘生药品工业株式会社 | 2019-03-29 | — | — | CN | disclosed |
| CN-107206343-A | Assign the microcapsules of strong vanilla odor aromatic | 弗门尼舍有限公司 | 2017-09-26 | — | — | CN | disclosed |
| CN-104619702-B | Fused cyclopentyl antagonists of CCR2 | 詹森药业有限公司 | 2017-09-15 | — | — | CN | disclosed |
| CN-107108836-A | Two-component composition | SIKA技术股份公司 | 2017-08-29 | — | — | CN | disclosed |
| CN-106986867-A | It is used as the heterocyclic radical amine of PI3K inhibitor | 因塞特控股公司 | 2017-07-28 | — | — | CN | disclosed |
| CN-102816540-B | Binding system comprising adhesive or sealant and tackifier | SIKA技术股份公司 | 2017-07-18 | — | — | CN | disclosed |
| CN-104812766-B | For the method for synthesizing amino alkylene phosphonic acids | 斯特雷特马克控股股份公司 | 2017-06-06 | — | — | CN | disclosed |
| CN-102648230-B | The extremely low low viscosity epoxy resin compositions of blushing | SIKA技术股份公司 | 2017-03-01 | — | — | CN | disclosed |
| CN-106132928-A | Novel anil, medical composition and its use containing described derivant | 橘生药品工业株式会社 | 2016-11-16 | — | — | CN | disclosed |
| US-20040181094-A1 | Transition metal oxo complexes as catalysts of synthetic processes involving alkyne reactants | REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE | 2004-09-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040181094-A1 | Transition metal oxo complexes as catalysts of synthetic processes involving alkyne reactants | POLR1G, PYM1, APEX1 | CA2 1806/4885CA1 1493/4885MAPK1 4675/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.